Cargando…
Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
Glioblastoma is one of the most difficult tumor types to treat with conventional therapy options like tumor debulking and chemo- and radiotherapy. Immunotherapeutic agents like oncolytic viruses, immune checkpoint inhibitors, and chimeric antigen receptor T cells have revolutionized cancer therapy,...
Autores principales: | Suryawanshi, Yogesh R., Schulze, Autumn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310195/ https://www.ncbi.nlm.nih.gov/pubmed/34372501 http://dx.doi.org/10.3390/v13071294 |
Ejemplares similares
-
MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model
por: Suryawanshi, Yogesh R., et al.
Publicado: (2021) -
Designing and building oncolytic viruses
por: Maroun, Justin, et al.
Publicado: (2017) -
CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies
por: Stadtmauer, Edward, et al.
Publicado: (2017) -
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
por: Jiang, Shan, et al.
Publicado: (2023) -
Collateral Lethal Effects of Complementary Oncolytic Viruses
por: Maroun, Justin W., et al.
Publicado: (2020)